Japan says drugmaker Gilead’s COVID-19 treatment remdesivir now in use in hospitals
By Ritu, Capital Sands Japan has begun treating severely ill COVID-19 patients with Gilead Sciences Inc’s COVID-19 remdesivir drug, a health ministry official said, just days after giving the drug emergency approval as it seeks to curb the coronavirus outbreak. Ministry official Yasuyuki Sahara said in an e-mail on Thursday that the U.S. firm’s treatment has been distributed to hospitals […]